🚨 side project alert 🚨 Announcing Muse Gadgets, an open source ESP32 firmware and Linux sdk so that you can make hardware devices that work with Muse. Grab an API token from gadgets.muse.ai and point your favorite coding agent at the github repo to build your own peripherals for Muse.

How it feels after you calm down

Hey Matan - CEO of Cognition here. I respect the work you have done at Factory but your allegations here about Cognition are not true. We have no interest in Factory’s info and Chris has never brought it up. He has not shared and would never share any information about you or Factory with our team, nor would we ever ask. Similarly, we would never ask our engineers or anyone on our team to collect info about any competitor under-the-table. Chris is an advisor to at least 10 companies, and he told you he was resigning as an advisor on Monday. The truth is we both wanted Chris and for good reason - he is a living legend with an unmatched reputation for results and integrity. Not only is he the only person who has built a sales org from the first sales hire to over 3B, he also has built incredible teams that he cares deeply about. His people love working for him. Again, I have a lot of respect for what you’ve built, but competing with integrity doesn’t include posts like yours.

French President Macron: China is massacring our industrial base — partly through innovation after Covid, but also by subsidizing its companies eight times the OECD average. That is not acceptable. We are not respecting the rules of the game, and we are not protecting our companies. We Europeans have been naive. We said: "We are open to everyone because we want to trade with others." But in reality, we are doing much less trade with others.

Breakthroughs in frontier science rarely come from a sudden stroke of luck. Every major leap in AI drug design is the product of years of method development, rigorous engineering, and learning from what came before. Witnessing the rapid advances in deep reinforcement learning and frontier AI capabilities led to a deep conviction: we could apply these same computational principles to other complex fields, like the engineering of new medicines. That thinking led to the formation of Isomorphic Labs in 2021. Now, five years on, we have compelling evidence that our AI can unlock therapeutics to a wide range of disease classes. We are confident this technology will fundamentally impact how new medicines are created, from early discovery all the way through development. In this article, I share the massive opportunity we have to transform human health with AI, and offer a look at the real, measurable progress we’re already making today. isomorphiclabs.com/articles/…

General Intuition has raised another $220M at a $6.2B valuation as we start making our models available. These are an entirely new class of foundation models, trained on billions of action-labeled videos, capable of acting in realtime in never seen before environments. 1/6